Vical, Inc. (VICL)
$3.05
-0.02 (-0.65%)
| CAPS Rating |
|
|---|---|
| Open | $3.07 |
| Previous Close | $3.07 |
| Daily Range | $3.02 - $3.13 |
| 52-Week Range | $1.04 - $5.51 |
| Market Cap | $158.03M |
| P/E Ratio | 0.00 |
| Dividend (Yield) | N/A (N/A) |
| Volume | 385,926 |
| Average Daily Volume | 542,000 |
How do you think VICL will perform vs the S&P 500?
Caps
Motley Fool CAPS is a community working together to find better stocks and to become better investors.
VICL Advanced Details
- CAPS Community Analysis: Commentary, Scorecard
- Advanced Financial Analysis: Historical Prices, Chart, Stats, Ratios, Earnings/Growth Rates, Statements, SEC Filings
VICL News and Commentary
- UPDATE 1-Vical gets funds from US Navy to produce H1N1 vaccine – Reuters
- UPDATE 1-Vical: Adjuvant-based cancer vaccine promising in mice – Reuters
- UPDATE 2-Vical says H1N1 vaccine showed promise in animals – Reuters
- 5 Stocks Bucking the Downtrend – The Motley Fool
- UPDATE 1-Vical gets new patent for flu vaccine, shares jump – Reuters
- Swine Flu – Blog at The Motley Fool
- VICL H1Ni flu vaccine – Blog at The Motley Fool
- Unloved Stocks Ready to Shine – The Motley Fool
Related News and Articles
- A Big Upgrade for Allos Therapeutics – The Motley Fool
- Now's a Great Time to Invest -- So Don't Blow It Like This – The Motley Fool
- This Stock Is a Train Wreck – The Motley Fool
- Drug Lowers Cholesterol; Stock Follows – The Motley Fool
- The Hottest Sector for 2010 – The Motley Fool
- Abbott: Brave or Stupid? – The Motley Fool
- 5-Star Stocks Poised to Pop: American Oriental Bioengineering – The Motley Fool
- Do You Have the Guts to Buy? – The Motley Fool
- This Top Stock Is a Winner – The Motley Fool
- Amylin Scores a Hat Trick – The Motley Fool


RSS Headlines
Fool UK